Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Tucatinib on Cardiac Repolarization in Healthy Volunteers
Authors
Keywords
-
Journal
DRUGS IN R&D
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-09-26
DOI
10.1007/s40268-023-00440-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bioanalysis of tucatinib and metabolite, and a five-way cross-validation to support clinical pharmacokinetic analysis
- (2023) Julie A Meyer et al. Bioanalysis
- LBA-2 Primary analysis of MOUNTAINEER: A phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC
- (2022) J. Strickler et al. ANNALS OF ONCOLOGY
- Evaluation of Safety and Clinically Relevant Drug–Drug Interactions with Tucatinib in Healthy Volunteers
- (2022) Ariel Topletz-Erickson et al. CLINICAL PHARMACOKINETICS
- The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic Impairment
- (2022) Ariel R. Topletz-Erickson et al. CLINICAL PHARMACOKINETICS
- QT Prolongation in Cancer Patients
- (2021) Peter Kim et al. Frontiers in Cardiovascular Medicine
- Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis
- (2021) G. Curigliano et al. ANNALS OF ONCOLOGY
- HERG channel and cancer: A mechanistic review of carcinogenic processes and therapeutic potential
- (2020) Siyi He et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Preclinical Activity of HER2-Selective Tyrosine Kinase Inhibitor Tucatinib as a Single Agent or in Combination with Trastuzumab or Docetaxel in Solid Tumor Models
- (2020) Anita Kulukian et al. MOLECULAR CANCER THERAPEUTICS
- QT Assessment in Early Drug Development: The Long and the Short of It
- (2019) Robert M. Lester et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prevalence of QTc Prolongation in Patients With Advanced Cancer Receiving Palliative Care—A Cause for Concern?
- (2019) Janet R. Hardy et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
- (2019) Rashmi K. Murthy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer
- (2018) S Siena et al. ANNALS OF ONCOLOGY
- Sex-related Differences in Drug-induced QT Prolongation and Torsades de Pointes: a New Model System with Human iPSC-CMs
- (2018) Jianhua Huo et al. TOXICOLOGICAL SCIENCES
- Statistical Characteristics of Moxifloxacin-Induced QTc Effect
- (2010) Lihan K. Yan et al. Journal of Biopharmaceutical Statistics
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started